Globeflex Capital L P Exelixis, Inc. Transaction History

Globeflex Capital L P

$1.03 Billion
Q3 2024

A detailed history of Globeflex Capital L P transactions in Exelixis, Inc. stock. As of the latest transaction made, Globeflex Capital L P holds 320,951 shares of EXEL stock, worth $11.1 Million. This represents 0.81% of its overall portfolio holdings.

Number of Shares

320,951

Previous 217,676 47.44%

Holding current value

$11.1 Million

Previous $4.89 Million 70.27%

% of portfolio

0.81%

Previous 0.52%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$21.96 - $27.6 $2.27 Million - $2.85 Million	103,275 Added 47.44%	320,951 $8.33 Million
Q2 2024 Aug 13, 2024	BUY	$20.34 - $23.73 $142,380 - $166,110	7,000 Added 3.32%	217,676 $4.89 Million
Q4 2023 Feb 13, 2024	SELL	$19.25 - $24.13 $249,922 - $313,279	-12,983 Reduced 5.8%	210,676 $5.05 Million
Q3 2023 Nov 13, 2023	BUY	$19.04 - $22.74 $2.1 Million - $2.51 Million	110,166 Added 97.07%	223,659 $4.89 Million
Q2 2023 Aug 14, 2023	BUY	$18.17 - $20.48 $83,582 - $94,208	4,600 Added 4.22%	113,493 $2.17 Million
Q4 2022 Feb 10, 2023	SELL	$14.96 - $17.39 $299,499 - $348,147	-20,020 Reduced 15.53%	108,893 $1.75 Million
Q3 2022 Nov 14, 2022	BUY	$15.68 - $22.27 $1.54 Million - $2.18 Million	97,977 Added 316.71%	128,913 $2.02 Million
Q4 2021 Feb 10, 2022	SELL	$15.84 - $21.88 $202,656 - $279,932	-12,794 Reduced 29.26%	30,936 $566,000
Q1 2021 May 14, 2021	BUY	$20.53 - $25.22 $897,776 - $1.1 Million	43,730 New	43,730 $988,000
Q4 2020 Feb 11, 2021	SELL	$18.39 - $24.8 $764,012 - $1.03 Million	-41,545 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$20.67 - $26.94 $242,686 - $316,302	-11,741 Reduced 22.03%	41,545 $1.02 Million
Q2 2020 Aug 12, 2020	SELL	$16.46 - $27.42 $250,093 - $416,619	-15,194 Reduced 22.19%	53,286 $1.27 Million
Q1 2020 May 13, 2020	SELL	$14.46 - $21.8 $39,042 - $58,860	-2,700 Reduced 3.79%	68,480 $1.18 Million
Q4 2019 Feb 07, 2020	BUY	$15.15 - $18.89 $15,710 - $19,588	1,037 Added 1.48%	71,180 $1.25 Million
Q2 2019 Aug 12, 2019	SELL	$18.93 - $24.75 $127,077 - $166,146	-6,713 Reduced 8.73%	70,143 $1.5 Million
Q1 2019 May 10, 2019	BUY	$19.6 - $24.76 $423,399 - $534,865	21,602 Added 39.1%	76,856 $1.83 Million
Q3 2018 Nov 09, 2018	BUY	$15.87 - $22.4 $330,096 - $465,919	20,800 Added 60.37%	55,254 $979,000
Q2 2018 Aug 10, 2018	BUY	$18.56 - $22.45 $489,130 - $591,647	26,354 Added 325.36%	34,454 $741,000
Q4 2017 Feb 13, 2018	BUY	$24.23 - $30.93 $196,263 - $250,533	8,100	8,100 $246,000

Others Institutions Holding EXEL

# of Institutions

498

Shares Held

244M

Call Options Held

2.54M

Put Options Held

2.29M

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.1B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Globeflex Capital L P, based on Form 13F filings with the SEC.

News

Stay updated on Globeflex Capital L P with notifications on news.

Account

Globeflex Capital L P Exelixis, Inc. Transaction History